%0
Generic
%T
Efficacy and Determinants of Response to HER Kinase Inhibition inHER2-Mutant Metastatic Breast Cancer
%A Smyth, Lillian M.
%A Piha-Paul, Sarina A.
%A Won, Helen H.
%A Schram, Alison M.
%A Saura, Cristina
%A Loi, Sherene
%A Lu, Janice
%A Shapiro, Geoffrey I.
%A Juric, Dejan
%A Mayer, Ingrid A.
%A Arteaga, Carlos L.
%A de la Fuente, Macarena I.
%A Brufksy, Adam M.
%A Spanggaard, Iben
%A Mau-Sørensen, Morten
%A Arnedos, Monica
%A Moreno, Victor
%A Boni, Valentina
%A Sohn, Joohyuk
%A Schwartzberg, Lee S.
%A Gonzàlez-Farré, Xavier
%A Cervantes, Andrés
%A Bidard, François-Clement
%A Gorelick, Alexander N.
%A Lanman, Richard B.
%A Nagy, Rebecca J.
%A Ulaner, Gary A.
%A Chandarlapaty, Sarat
%A Jhaveri, Komal
%A Gavrila, Elena I.
%A Zimel, Catherine
%A Selcuklu, S. Duygu
%A Melcer, Myra
%A Samoila, Aliaksandra
%A Cai, Yanyan
%A Scaltriti, Maurizio
%A Mann, Grace
%A Xu, Feng
%A Eli, Lisa D.
%A Dujka, Melanie
%A Lalani, Alshad S.
%A Bryce, Richard
%A Baselga, José
%A Taylor, Barry S.
%A Solit, David B.
%A Meric-Bernstam, Funda
%A Hyman, David M.
%I American Association for Cancer Research (AACR)
%@ 2159-8274
%@ 2159-8290
%D 2020
%C American Association for Cancer Research (AACR)